Cargando…
Cost‑effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer
BACKGROUND: Helicobacter pylori (H. pylori) eradication therapy has been shown to reduce the risk of gastric cancer in patients who have a family history of gastric cancer in first-degree relatives. The aim of this study was to assess the cost-effectiveness of H. pylori eradication therapy in a sele...
Autores principales: | Zheng, Hanrui, Xie, Qian, Zhan, Mei, Jin, Chaohui, Li, Qiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837576/ https://www.ncbi.nlm.nih.gov/pubmed/33519193 http://dx.doi.org/10.2147/PPA.S286860 |
Ejemplares similares
-
Effect of gastric microbiota on quadruple Helicobacter pylori eradication therapy containing bismuth
por: Niu, Zhan-Yue, et al.
Publicado: (2021) -
Impact of Helicobacter pylori eradication on the gastric microbiome
por: Mao, Li-Qi, et al.
Publicado: (2021) -
Degree of Gastric Mucosal Atrophy Correlated Well with Gastric Cancer Occurrence in Patients with Helicobacter pylori-eradicated Status
por: Adachi, Kyoichi, et al.
Publicado: (2022) -
Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy
por: Kim, Sung Eun, et al.
Publicado: (2015) -
Effect of Eradication of Helicobacter pylori on Expression Levels of FHIT, IL-8 and P73 in Gastric Mucosa of First-Degree Relatives of Gastric Cancer Patients
por: Liao, Juan, et al.
Publicado: (2015)